Skip to main content
Log in

Increase in serum cardiac myosin light chain I associated with elective percutaneous transluminal coronary angioplasty in patients with ischemic heart disease

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Changes in serum myosin light chain I (MLCI) due to elective percutaneous transluminal coronary angioplasty (PTCA) were studied after PTCA (0, 8 and 48 hours) in 57 patients with old myocardial infarction (MI group) and 20 patients with angina pectoris (AP group). The AP group showed no increase after PTCA. In contrast, in the MI group there were 16 patients in whom MLCI at 48 hours was increased by 1.0 ng/m/ or more (MI1 group) and another group of 41 patients who showed no increase in MLCI (MI2 group). The MI1 group had a significantly higher incidence of (1) non-Q wave myocardial infarction (62.5% vs. 17.1%, p< 0.01), (2) 99% stenosis of a coronary artery (50.0% vs. 12.2%, p< 0.01), and (3) redistribution in a hypoperfusion area found in the delayed image of resting thallium-201 (201Tl) myocardial scintigraphy (85.7% vs. 15.8%, p< 0.01). The left ventricular ejection fraction (LVEF) was significantly improved in the MI1 group, 3 to 4 months later (from 0.49±0.12 to 0.58±0.l 1, p< 0.01), in contrast to the patient of MI2 group who did not show any improvement. The AP group was not considered to have a bulk of myocardium impaired enough to show a release of MLCI due to PTCA-associated transient coronary occlusion. In the MI1 group, however, MLCI was probably released from the chronically underperfused, but still salvageable, portion of the myocardium. This is consistent with the improvement in LVEF observed 3 to 4 months after the relief of severe coronary stenosis. These findings suggest that the MI1 group had a large amount of “hibernating myocardium.”

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Isobe M, Nagai R, Ueda S, et al: Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarction.Circulation 76: 1251–1261, 1987

    PubMed  CAS  Google Scholar 

  2. Trahern CA, Gere JB, Krauth GH, et al: Clinical assessment of serum myosin light chains in the diagnosis of acute myocardial infarction.Am J Cardiol 41: 641–645, 1978

    Article  PubMed  CAS  Google Scholar 

  3. Heyndrickx GR, Millard RW, McRitchie RJ, et al: Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs.J Clin Invest 56: 978–985, 1975

    Article  PubMed  CAS  Google Scholar 

  4. Geft IL, Fishbein MC, Ninomiya K, et al: Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis.Circulation 66: 1150–1153, 1982

    PubMed  CAS  Google Scholar 

  5. Heyndrickx GR, Amano J, Kenna T, et al: Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons.J Am Coll Cardiol 6: 1299–1303, 1985

    PubMed  CAS  Google Scholar 

  6. Spadaro JJ, Ludbrook PA, Tiefenbrunn AJ, et al: Paucity of subtle myocardial injury after angioplasty delineated with MB CK.Cathet Cardiovasc Diag 12: 230–234, 1986

    Article  CAS  Google Scholar 

  7. Pauletto P, Piccolo D, Scannapieco G, et al: Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris.Am J Cardiol 59: 999–1000, 1987

    Article  PubMed  CAS  Google Scholar 

  8. Oh JK, Shub C, Ilstrup DM, et al: Creatine kinase release after successful percutaneous transluminal coronary angioplasty.Am Heart J 109: 1225–1231, 1985

    Article  PubMed  CAS  Google Scholar 

  9. Komamura K, Naka M, Nanto S, et al: Release of myocardial enzymes into coronary sinus by brief ischemia during percutaneous transluminal coronary angioplasty.Med J Osaka Police Hosp 10: 31–39, 1986 (in Japanese)

    Google Scholar 

  10. Suehiro M, Naruse H, Fukuda Y, et al: Fundamental and clinical evaluation of IRMA for serum cardiac myosin light chain I.Jpn J Nucl Med 27: 1183–1190, 1990 (in Japanese)

    CAS  Google Scholar 

  11. Sandier H, Dodge HT: The use of single plane angiocardiograms for the calculation of left ventricular volume in man.Am Heart J 75: 325–334, 1968

    Article  Google Scholar 

  12. Khaw BA, Gold HK, Fallon JT, et al: Detection of serum cardiac myosin light chains in acute experimental myocardial infarction: radioimmunoassay of cardiac myosin light chains.Circulation 58: 1130–1136, 1978

    PubMed  CAS  Google Scholar 

  13. Smitherman TC, Dycus DW, Richards EG: Dissociation of myosin light chains and decreased myosin ATPase activity with acidification of synthetic myosin filaments: possible clues to the fate of myosin in myocardial ischemia and infarction.J Mol Cell Cardiol 12: 149–164, 1980

    Article  PubMed  CAS  Google Scholar 

  14. Nixon JV: Southwestern Internal Medicine Conference, Non-Q-wave myocardial infarction.Am J Med Sci 292: 173–181, 1986

    Article  PubMed  CAS  Google Scholar 

  15. Gibson RS, Beller GA, Gheorghiade M, et al: The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study.Circulation 73: 1186–1198, 1986

    PubMed  CAS  Google Scholar 

  16. Wahl JM, Hakki AH, Iskandrian AS, et al: Scintigraphic characterization of Q wave and non-Q-wave acute myocardial infarction.Am Heart J 109: 769–775, 1985

    Article  PubMed  CAS  Google Scholar 

  17. Mori T, Yamabe H, Yoshida H, et al: The significance of resting thallium-201 delayed SPECT for assessing viability of infarcted regions—comparison with exercise thallium-201 SPECT—.Jpn Circ J 55: 99–108, 1991

    PubMed  CAS  Google Scholar 

  18. Rozanski A, Berman DS, Gray R, et al: Use of Thallium-201 redistribution scintigraphy in the preoperative differentiation of reversible and nonreversible myocardial asynergy.Circulation 64: 936–944, 1981

    PubMed  CAS  Google Scholar 

  19. Iskandrian AS, Hakki AH, Kane SA, et al: Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting.Am J Cardiol 51: 1312–1316, 1983

    Article  PubMed  CAS  Google Scholar 

  20. Suryapranta H, Serruys PW, Beatt K, et al: Recovery of regional myocardial dysfunction after successful coronary angioplasty early after a non-Q wave myocardial infarction.Am Heart J 120: 261–269, 1990

    Article  Google Scholar 

  21. Braunwald E, Rutherford JD: Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”.J Am Coll Cardiol 8: 1467–1470, 1986

    PubMed  CAS  Google Scholar 

  22. Cohen M, Charney R, Hershman R, et al: Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty.J Am Coll Cardiol 12: 1193–1198, 1988

    Article  PubMed  CAS  Google Scholar 

  23. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation 74: 1124–1136, 1986

    PubMed  CAS  Google Scholar 

  24. Deutsch E, Berger M, Kussmaul WG, et al: Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.Circulation 82: 2044–2051, 1990

    PubMed  CAS  Google Scholar 

  25. Miura T, Goto M, Urabe K, et al: Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning?Circulation 84: 2504–2512, 1991

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, H., Gotoh, K., Yagi, Y. et al. Increase in serum cardiac myosin light chain I associated with elective percutaneous transluminal coronary angioplasty in patients with ischemic heart disease. Ann Nucl Med 6, 261–268 (1992). https://doi.org/10.1007/BF03164664

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164664

Key words

Navigation